Search research articles
Contact Us
Filters
Showing results (51-60 of 113) with videos related to
Page
of 12
Sort By:
Cancer Research
|
October 15, 1990
Human homologue of Moloney leukemia virus integration-4 locus (MLVI-4), located 20 kilobases 3' of the myc gene, is rearranged in multiple myelomas
A P Palumbo, M Boccadoro, S Battaglio, et al.
Hypertension (Dallas, Tex. : 1979)
|
March 1, 1987
Increased basal and thrombin-induced free calcium in platelets of essential hypertensive patients
A Lechi, C Lechi, G Bonadonna, et al.
Archives of Internal Medicine
|
March 20, 2001
What do the people think (and know) about informed consent for participation in a medical trial
D Dazzi, B Agnetti, L Bandini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2002
Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer
P Corradini, C Voena, M Astolfi, et al.
Nature Genetics
|
November 5, 1997
Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma
S Iida, P H Rao, M Butler, et al.
Bone Marrow Transplantation
|
November 16, 2004
Use of intrathecal prophylaxis in allogeneic haematopoietic stem cell transplantation for malignant blood diseases: a survey of the European Group for Blood and Marrow Transplantation (EBMT)
T Ruutu, P Corradini, A Gratwohl, et al.
Cell
|
December 20, 1991
B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50
A Neri, C C Chang, L Lombardi, et al.
Blood
|
September 15, 1993
Rapid generation of antiplasma cell activity in the bone marrow of myeloma patients by CD3-activated T cells
M Massaia, C Attisano, S Peola, et al.
Leukemia
|
April 14, 2000
Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft
C Tarella, D Caracciolo, P Corradini, et al.
Bone Marrow Transplantation
|
October 2, 2003
Detection of minimal residual disease by real-time PCR can be used as a surrogate marker to evaluate the graft-versus-myeloma effect after allogeneic stem cell transplantation
C Voena, M Malnati, I Majolino, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 113) with videos related to
Sort By:
Page
of 12
Cancer Research
|
October 15, 1990
Human homologue of Moloney leukemia virus integration-4 locus (MLVI-4), located 20 kilobases 3' of the myc gene, is rearranged in multiple myelomas
A P Palumbo, M Boccadoro, S Battaglio, et al.
Hypertension (Dallas, Tex. : 1979)
|
March 1, 1987
Increased basal and thrombin-induced free calcium in platelets of essential hypertensive patients
A Lechi, C Lechi, G Bonadonna, et al.
Archives of Internal Medicine
|
March 20, 2001
What do the people think (and know) about informed consent for participation in a medical trial
D Dazzi, B Agnetti, L Bandini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2002
Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer
P Corradini, C Voena, M Astolfi, et al.
Nature Genetics
|
November 5, 1997
Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma
S Iida, P H Rao, M Butler, et al.
Bone Marrow Transplantation
|
November 16, 2004
Use of intrathecal prophylaxis in allogeneic haematopoietic stem cell transplantation for malignant blood diseases: a survey of the European Group for Blood and Marrow Transplantation (EBMT)
T Ruutu, P Corradini, A Gratwohl, et al.
Cell
|
December 20, 1991
B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50
A Neri, C C Chang, L Lombardi, et al.
Blood
|
September 15, 1993
Rapid generation of antiplasma cell activity in the bone marrow of myeloma patients by CD3-activated T cells
M Massaia, C Attisano, S Peola, et al.
Leukemia
|
April 14, 2000
Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft
C Tarella, D Caracciolo, P Corradini, et al.
Bone Marrow Transplantation
|
October 2, 2003
Detection of minimal residual disease by real-time PCR can be used as a surrogate marker to evaluate the graft-versus-myeloma effect after allogeneic stem cell transplantation
C Voena, M Malnati, I Majolino, et al.
Page
of 12